{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T21:40:10Z","timestamp":1789940410405,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T00:00:00Z","timestamp":1484265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Hospital Central de Policia Nacional del Peru"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Brasileira de Hematologia e Hemoterapia"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.bjhh.2016.11.007","type":"journal-article","created":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T15:32:00Z","timestamp":1485185520000},"page":"102-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Seroprevalence, cost per donation and reduction in blood supply due to positive and indeterminate results for infectious markers in a blood bank in Lima, Peru"],"prefix":"10.1016","volume":"39","author":[{"given":"Jeel","family":"Moya-Salazar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Ubidia-Incio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maritza","family":"Incio-Grande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorgelina L.","family":"Blejer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9352","key":"10.1016\/j.bjhh.2016.11.007_bib0210","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0140-6736(03)12195-2","article-title":"Transfusion medicine: looking to the future","volume":"361","author":"Goodnough","year":"2003","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.bjhh.2016.11.007_bib0215","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1537-2995.1994.341095026978.x","article-title":"Quality systems and total process control in blood banking","volume":"34","author":"Callery","year":"1994","journal-title":"Transfusion (Paris)"},{"issue":"Suppl. 2","key":"10.1016\/j.bjhh.2016.11.007_bib0220","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/S1386-6532(05)80038-1","article-title":"Safety of blood supply in the Caribbean countries: role of screening blood donors for markers of hepatitis B and C viruses","volume":"34","author":"Cruz","year":"2005","journal-title":"J Clin Virol"},{"key":"10.1016\/j.bjhh.2016.11.007_bib0225","series-title":"AABB technical manual","first-page":"613","article-title":"Transfusion-transmitted disease","author":"American Association of Blood Banks","year":"2002"},{"key":"10.1016\/j.bjhh.2016.11.007_bib0230","series-title":"Manual de Medicina Transfusional","first-page":"11","author":"Vega","year":"1994"},{"issue":"4","key":"10.1016\/j.bjhh.2016.11.007_bib0235","doi-asserted-by":"crossref","first-page":"6","DOI":"10.24265\/horizmed.2014.v14n4.02","article-title":"Seroprevalence infectious markers causing loss of donation in the blood bank service in Hospital Nacional Docente Madre \u2013 Ni\u00f1o San Bartolome January 2008 to December 2013","volume":"14","author":"Moya","year":"2014","journal-title":"Horiz Med"},{"issue":"4","key":"10.1016\/j.bjhh.2016.11.007_bib0240","first-page":"579","article-title":"Investigation of anti-HTLV-I\/II seroprevalence in healthy blood donors in Izmir region, Turkey","volume":"44","author":"Sert\u00f6z","year":"2010","journal-title":"Mikrobiyol Bul"},{"issue":"2","key":"10.1016\/j.bjhh.2016.11.007_bib0245","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1473-3099(01)00065-2","article-title":"Clinical an epidemiological aspects of Chagas disease","volume":"1","author":"Prata","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bjhh.2016.11.007_bib0250","series-title":"Revised Precautionary Measures to reduce the possible risk of transmission of Creutzfeldt\u2013Jakob Disease (CJD) and new variant Creutzfeldt\u2013Jakob Disease (nvCJD) by blood and blood products","first-page":"3","author":"Center of Biologics Evaluation and Research","year":"1999"},{"issue":"Suppl. 2","key":"10.1016\/j.bjhh.2016.11.007_bib0255","first-page":"VII","article-title":"Overall Blood Supply Strategy with regard to variant Creutzfeldt\u2013Jakob Disease (vCJD). Report of the Working Group Commissioned by the German Federal Ministry of Health April 13, 2006","volume":"33","author":"Geman Federal Ministry of Health","year":"2006","journal-title":"Transfus Med Hemother"},{"issue":"36","key":"10.1016\/j.bjhh.2016.11.007_bib0260","first-page":"842","article-title":"Transfusion-associated transmission of West Nilen Virus \u2013 Arizona, 2004","volume":"53","author":"Center for Disease Control and Prevention (CDC)","year":"2004","journal-title":"Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.bjhh.2016.11.007_bib0265","first-page":"389","article-title":"The risk of malaria transmission by blood transfusion at Cotonou, Benin","volume":"10","author":"Kindel-Gazard","year":"2000","journal-title":"Sante"},{"issue":"3","key":"10.1016\/j.bjhh.2016.11.007_bib0270","first-page":"259","article-title":"Riesgo de transmisi\u00f3n de infecciones por v\u00eda transfusional","volume":"62","author":"Blejer","year":"2002","journal-title":"Medicina (BAires)"},{"issue":"1","key":"10.1016\/j.bjhh.2016.11.007_bib0275","doi-asserted-by":"crossref","first-page":"3","DOI":"10.25100\/cm.v27i.1.4","article-title":"Prevalencia de marcadores para infecciones transmisibles por transfusi\u00f3n en donantes voluntarios","volume":"27","author":"Cort\u00e9s","year":"1996","journal-title":"Colomb Med"},{"issue":"4","key":"10.1016\/j.bjhh.2016.11.007_bib0280","doi-asserted-by":"crossref","first-page":"137","DOI":"10.20453\/rmh.v10i4.616","article-title":"Marcadores serol\u00f3gicos de s\u00edfilis, hepatitis B y VIH en donantes d sangre en el Hospital Nacional Cayetano Heredia, Lima \u2013 Per\u00fa","volume":"10","author":"De la Cruz","year":"1999","journal-title":"Rev Med Hered"},{"key":"10.1016\/j.bjhh.2016.11.007_bib0285","series-title":"Supply of blood for transfusion in Latin American and Caribbean countries 2012 and 2013","author":"Pan-American Health Organization","year":"2015"},{"key":"10.1016\/j.bjhh.2016.11.007_bib0290","series-title":"El pr\u00f3ximo cuadrienio","author":"Alleyne","year":"1998"},{"key":"10.1016\/j.bjhh.2016.11.007_bib0295","series-title":"Sistema de Gesti\u00f3n de la Calidad del PRONAHEBAS. Manual de Calidad. Norma T\u00e9cnica. No. 011-MINSA\/DGSP-V.01","author":"Ministerio de Salud","year":"2004"},{"key":"10.1016\/j.bjhh.2016.11.007_bib0300","series-title":"Standards for blood banks and transfusion services","author":"AABB","year":"2014"},{"issue":"1","key":"10.1016\/j.bjhh.2016.11.007_bib0305","doi-asserted-by":"crossref","first-page":"31","DOI":"10.24265\/horizmed.2017.v17n1.06","article-title":"Depletion of blood supply and cost for indeterminate donations at Hospital Nacional Guillermo Almenara Irigoyen","volume":"17","author":"Moya","year":"2017","journal-title":"Horiz Med"},{"issue":"2","key":"10.1016\/j.bjhh.2016.11.007_bib0310","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1201-9712(01)90032-3","article-title":"Antibodies to Trypanosoma cruzi among blood donors in Buenos Aires, Argentina","volume":"5","author":"Blejer","year":"2001","journal-title":"Int J Infect Dis"},{"issue":"3","key":"10.1016\/j.bjhh.2016.11.007_bib0315","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1423-0410.2008.01088.x","article-title":"Trans-sialidase Inhibition Assay for the detection of Trypanosoma cruzi infection in blood donor samples from Argentina","volume":"95","author":"Blejer","year":"2008","journal-title":"Vox Sang"},{"issue":"8","key":"10.1016\/j.bjhh.2016.11.007_bib0320","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.eimc.2012.02.002","article-title":"ARCHITECT Chagas\u00ae: una nueva herramienta diagn\u00f3stica en la enfermedad de Chagas","volume":"30","author":"Iborra-Bendicho","year":"2012","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"1","key":"10.1016\/j.bjhh.2016.11.007_bib0325","first-page":"63","article-title":"Resultados en zona gris del tamizaje para VIH y VHC, pueden indicar seroconversi\u00f3n inmediata","volume":"52","author":"Aguirre","year":"2005","journal-title":"Rev Mex Patol Clin"},{"key":"10.1016\/j.bjhh.2016.11.007_bib0330","series-title":"Principles and practice of the infectious diseases","first-page":"2117","article-title":"Treponema pallidum (syphilis)","author":"Tramont","year":"1995"},{"issue":"6","key":"10.1016\/j.bjhh.2016.11.007_bib0335","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bjhh.2015.08.004","article-title":"Health-related quality of life among blood donors with hepatitis B and hepatitis C: longitudinal study before and after diagnosis","volume":"37","author":"Porto","year":"2015","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"1","key":"10.1016\/j.bjhh.2016.11.007_bib0340","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0377-1237(08)80142-6","article-title":"Infectious disease markers in blood donors","volume":"64","author":"Chattoraj","year":"2008","journal-title":"Med J Armed Forces India"},{"issue":"1","key":"10.1016\/j.bjhh.2016.11.007_bib0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2009.06.001","article-title":"The search for infectious causes of human cancers: where and why","volume":"392","author":"Zur Hausen","year":"2009","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.bjhh.2016.11.007_bib0350","first-page":"400","article-title":"Indeterminate HTLV serologic results in U.S. blood donors: are they due to HTLV-I or HTLV-II?","volume":"5","author":"Khabbaz","year":"1992","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"10.1016\/j.bjhh.2016.11.007_bib0355","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1537-2995.1995.35295125745.x","article-title":"Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors","volume":"35","author":"Busch","year":"1995","journal-title":"Transfusion"},{"issue":"1\u20132","key":"10.1016\/j.bjhh.2016.11.007_bib0360","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jviromet.2010.06.002","article-title":"Evaluation of a rapid and simple fourth-generation HIV screening assay for qualitative detection of HIV p24 antigen and\/or antibodies to HIV-1 and HIV-2","volume":"168","author":"Beelaert","year":"2010","journal-title":"J Virol Methods"},{"key":"10.1016\/j.bjhh.2016.11.007_bib0365","series-title":"Laboratory testing for the diagnosis of HIV infection. Updated recommendations","author":"Branson","year":"2014"},{"issue":"99","key":"10.1016\/j.bjhh.2016.11.007_bib0370","first-page":"29842","article-title":"Requirements for blood and blood components intended for transfusion or for further manufacturing use","volume":"80","author":"Food and Drug Administration (FDA)","year":"2015","journal-title":"Fed Regist"},{"key":"10.1016\/j.bjhh.2016.11.007_bib0375","series-title":"Blood safety and availability","author":"World Health Organization (WHO)","year":"2015"},{"key":"10.1016\/j.bjhh.2016.11.007_bib0380","series-title":"Report of the survey on blood supply management organised by the TS003 Working Group in member states and observer states of the Council of Europe","author":"Alen","year":"2014"},{"issue":"1","key":"10.1016\/j.bjhh.2016.11.007_bib0385","first-page":"41","article-title":"Marcadores serol\u00f3gicos causantes de p\u00e9rdidas de donaciones","volume":"29","author":"Viamonte","year":"2000","journal-title":"Rev Cubana Med Milit"},{"issue":"2","key":"10.1016\/j.bjhh.2016.11.007_bib0390","first-page":"66","article-title":"Costos en la Transfusi\u00f3n Sangu\u00ednea","volume":"23","author":"S\u00e1nchez","year":"2000","journal-title":"Rev Mex Anest"},{"key":"10.1016\/j.bjhh.2016.11.007_bib0395","series-title":"Seguridad en Medicina Transfusional. Menarini Diagn\u00f3stics","first-page":"73","author":"Grifols","year":"1998"},{"key":"10.1016\/j.bjhh.2016.11.007_bib0400","series-title":"XV Congreso Argentino De Medicina Transfusional","first-page":"215","article-title":"Planificaci\u00f3n Anal\u00edtica de la calidad en Pruebas cualitativas de tamizaje serol\u00f3gico de Banco de Sangre","author":"Moya-Salazar","year":"2015"},{"key":"10.1016\/j.bjhh.2016.11.007_bib0405","series-title":"Norma Internacional 9001:2000. Sistemas de gesti\u00f3n de la calidad-Requisitos","author":"ISO","year":"2000"},{"issue":"Suppl. 1","key":"10.1016\/j.bjhh.2016.11.007_bib0410","doi-asserted-by":"crossref","first-page":"O16","DOI":"10.1186\/1742-4690-11-S1-O16","article-title":"Comparison of human T cell leukemia virus-1\/2 (HTLV-1\/2) screening assays in South America: implications in the loss of blood units","volume":"11","author":"Pataccini","year":"2014","journal-title":"Retrovirology"}],"container-title":["Revista Brasileira de Hematologia e Hemoterapia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1516848417300038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1516848417300038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T18:49:38Z","timestamp":1749926978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1516848417300038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1516848417300038"],"URL":"https:\/\/doi.org\/10.1016\/j.bjhh.2016.11.007","relation":{},"ISSN":["1516-8484"],"issn-type":[{"value":"1516-8484","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seroprevalence, cost per donation and reduction in blood supply due to positive and indeterminate results for infectious markers in a blood bank in Lima, Peru","name":"articletitle","label":"Article Title"},{"value":"Revista Brasileira de Hematologia e Hemoterapia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjhh.2016.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}